In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.
about
The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementiaIs Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunctionMultireceptor fingerprints in progressive supranuclear palsy.Seeding and transgenic overexpression of alpha-synuclein triggers dendritic spine pathology in the neocortexModern neuroimaging in psychiatry: towards the integration of functional and molecular information.Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.Is synaptic loss a unique hallmark of Alzheimer's disease?(18)F-Fluorodeoxyglucamines: Reductive amination of hydrophilic (18)F-fluoro-2-deoxyglucose with lipophilic amines for the development of potential PET imaging agents.Preparation of Graphene-Modified Acupuncture Needle and Its Application in Detecting Neurotransmitters.Identification of CSPα clients reveals a role in dynamin 1 regulation.Selective detection of dopamine in the presence of ascorbic acid via fluorescence quenching of InP/ZnS quantum dots.Fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain.Autoantibodies and the immune hypothesis in psychotic brain diseases: challenges and perspectives.Regulation of dopamine D₃ receptor in the striatal regions and substantia nigra in diffuse Lewy body disease.Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson's disease.Metabonomic studies of schizophrenia and psychotropic medications: focus on alterations in CNS energy homeostasis.The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.Alpha-synuclein: from secretion to dysfunction and death.Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy.Synaptic failure and α-synuclein.Synucleinopathies: common features and hippocampal manifestations.DAT versus D2 receptor binding in the rat striatum: l-DOPA-induced motor activity is better predicted by reuptake than release of dopamine.Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats.Relationship between L-DOPA-induced reduction in motor and exploratory activity and degree of DAT binding in the rat.Relationship Between L-DOPA-Induced Reduction in Motor and Exploratory Activity and Striatal Dopamine D2 Receptor Binding in the Rat.Effects of L-DOPA on striatal iodine-123-FP-CIT binding and behavioral parameters in the rat.Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders.Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's Disease.Selective Fluorimetric Detection of Primary Alkylamines by a Calix[6]arene Funnel Complex.Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism.Binding of [123I]iodobenzamide to the rat D2 receptor after challenge with various doses of methylphenidate: an in vivo imaging study with dedicated small animal SPECT.The Utility of the Combined Use of 123I-FP-CIT and 123I-MIBG Myocardial Scintigraphy in Differentiating Parkinson’s Disease from Other Parkinsonian Syndromes.Electrooxidation of dopamine at N-(1,3-dimethylbutyl)-N'-phenyl-p-phenylenediamine/multiwalled carbon nanotubes nanocomposite-modified electrodeNeuropsychiatric disturbances in atypical parkinsonian disorders
P2860
Q22252705-B9A615DD-D1A4-4454-A122-133D91393B68Q26801733-81322554-5FDF-4435-8300-926754BFF56EQ28506296-60B15B37-DC61-4ACD-A02F-023E5305A509Q33568690-5AF756C9-BA42-42CB-8B36-455AC544E300Q33625757-D8D18A88-5FA2-464A-B0B8-1ACBC2378BF2Q34015102-FB6E1B2B-7823-4D15-81B5-A00EE4806592Q34306084-CB51FD6F-F314-4E4E-9497-9639F6A0BC77Q34504659-60C62BF8-0115-481A-BD24-187B9EAE1DAAQ35747666-B048B63D-EA1B-42FA-BB8A-844FEC05C939Q35784286-3B04A1FD-51DA-4FBA-96B6-AB1DB9601BADQ35893528-0DC5F747-5B33-4820-A0E2-365E91F7D548Q36010415-E381FC77-E6E7-4E04-9B9D-FDB10505FD44Q36545674-5E3B25C8-7FDA-4E70-B9E5-F78B1BBB1DB0Q37154797-6329D4C3-9127-40AC-B5D3-07CC333D1730Q37228453-0A7A7B86-EFA6-4904-BAA0-4D880F3EBE4DQ37276021-C6DDD595-AF15-499C-9360-5F4093C3BC35Q37810163-8402D344-AB15-4EFD-989F-05B9FA8B728AQ37910636-4E7A8DF1-2DAA-4DB0-8D99-35FEF9F2F06EQ38028819-9908AA94-437F-4823-8762-AB4D6A87C918Q38101088-DE289A9C-B008-4922-A42C-C852A97C9B8BQ38704236-334392F2-323F-4639-8725-AAE0E865CE9AQ39003423-0A84FC22-AE90-45D4-8E94-BDBA854C34F0Q39778760-ED9B5C32-4025-4BD3-AACF-4A8D99E38312Q40923364-7AE19549-AC30-4C8B-BB7F-F8C860B09269Q41979764-3996FCAD-E4F7-4299-8703-E85B00E1062CQ42559340-D61CCB5D-4AC3-4837-B88A-6E2C6887CB2DQ42924776-49F2A904-95C2-4437-99AE-4D0298560B23Q47619917-E84BAE36-255C-4ACA-A8F6-476A1D52E3C5Q47999645-A6007074-3F33-4E49-B97B-5929587B7156Q52685691-EF9479B0-ECE5-48C9-BE21-35F17917EED7Q52692363-C61F1C87-75E6-4727-A7D4-2B6FD096D6A8Q52985613-B4E44519-826F-40FE-A349-CD481FA4BD21Q53258578-9713C277-C2B5-4163-82C6-6D6F5FF94202Q55344774-4141DE1B-9918-42DD-A043-D8D08EC2828AQ57381921-3A83A424-1A8F-4AF6-8F67-C4C5DA3CCDD3Q57817274-8803D475-6506-402C-B410-EE270A57EFF7
P2860
In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
In vivo imaging of synaptic fu ...... vement disorders and dementia.
@ast
In vivo imaging of synaptic fu ...... vement disorders and dementia.
@en
In vivo imaging of synaptic fu ...... vement disorders and dementia.
@nl
type
label
In vivo imaging of synaptic fu ...... vement disorders and dementia.
@ast
In vivo imaging of synaptic fu ...... vement disorders and dementia.
@en
In vivo imaging of synaptic fu ...... vement disorders and dementia.
@nl
altLabel
In vivo imaging of synaptic function in the central nervous system
@en
prefLabel
In vivo imaging of synaptic fu ...... vement disorders and dementia.
@ast
In vivo imaging of synaptic fu ...... vement disorders and dementia.
@en
In vivo imaging of synaptic fu ...... vement disorders and dementia.
@nl
P2093
P1476
In vivo imaging of synaptic fu ...... vement disorders and dementia.
@en
P2093
Christina Antke
Hans-Wilhelm Müller
Susanne Nikolaus
P356
10.1016/J.BBR.2009.06.008
P407
P577
2009-06-10T00:00:00Z